Freenome is a biotechnology company on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent their diseases. By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing simple blood tests to detect early-stage cancer and make treatments more effective.
The company has raised $238 million from investors such as RA Capital, Polaris Partners, Perceptive Advisors, Andreessen Horowitz, funds and accounts advised by T. Rowe Price Associates, Inc., GV (formerly Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society?s BrightEdge Ventures, Data Collective Venture Capital, and Verily Life Sciences (formerly Google Life Sciences).
B2B
101 to 250
Series C
$237.6M
Growth
2014
Healthcare
Health Care Facilities & Hospitals
And Machine Learning
Molecular Diagnostics
Multiomics
Revenue Growth
N/A
Yes
Active
Robotics and Control
Machine Learning
Machine Perception
Natural Language Processing
Knowledge Representation and Reasoning
N/A
Software
Aug 2020
- Freenome Raises $270M in Series C Round for Registration Study of CRC Liquid Biopsy Test
Aug 2019
- ADC Therapeutics and Freenome Enter Biomarker Development Collaboration
Jun 2018
- Christian Doppler Research Grant Awarded to Freenome and the Medical University
Senior Machine Learning Research Engineer
San Francisco, California
Machine Learning Scientist
San Francisco, California
Staff Software Engineer - Infrastructure
South San Francisco, CA
Staff Software Engineer, Backend
South San Francisco, CA
Software Engineer - Infrastructure
South San Francisco, CA
AI/ML Professionals
Want to work at Freenome?
We can introduce you to the right person at Freenome
4
1
$52M
Company was founded 2014 and it took almost 8 years (Dec 2022) to raise first external round
Investors
Interested in researching Freenome?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Freenome
Potential Customers
Interested in what they do or partnership?
Learn more about how they work